These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9335087)

  • 41. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
    Sánchez C; Hyttel J
    Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential effects of the 5-HT2 receptor antagonist on the anti-immobility effects of noradrenaline and serotonin reuptake inhibitors in the forced swimming test.
    Yamada J; Sugimoto Y
    Brain Res; 2002 Dec; 958(1):161-5. PubMed ID: 12468041
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Blood-cerebrospinal fluid and blood-brain barriers imaged by 18F-labeled metabolites of 18F-setoperone studied in humans using positron emission tomography.
    Blin J; Crouzel C
    J Neurochem; 1992 Jun; 58(6):2303-10. PubMed ID: 1573409
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Noradrenaline and serotonin reuptake inhibition as clinical principles: a review of antidepressant efficacy.
    Humble M
    Acta Psychiatr Scand Suppl; 2000; 402():28-36. PubMed ID: 10901156
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Loss of brain 5-HT2 receptors in Alzheimer's disease. In vivo assessment with positron emission tomography and [18F]setoperone.
    Blin J; Baron JC; Dubois B; Crouzel C; Fiorelli M; Attar-Lévy D; Pillon B; Fournier D; Vidailhet M; Agid Y
    Brain; 1993 Jun; 116 ( Pt 3)():497-510. PubMed ID: 8513389
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
    Hetrick S; Merry S; McKenzie J; Sindahl P; Proctor M
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004851. PubMed ID: 17636776
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 5HT2 receptors in cerebral cortex of migraineurs studied using PET and 18F-fluorosetoperone.
    Chabriat H; Tehindrazanarivelo A; Vera P; Samson Y; Pappata S; Boullais N; Bousser MG
    Cephalalgia; 1995 Apr; 15(2):104-8; discussion 77. PubMed ID: 7641243
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of fluvoxamine treatment on the in vivo binding of [F-18]FESP in drug naive depressed patients: a PET study.
    Moresco RM; Colombo C; Fazio F; Bonfanti A; Lucignani G; Messa C; Gobbo C; Galli L; Del Sole A; Lucca A; Smeraldi E
    Neuroimage; 2000 Oct; 12(4):452-65. PubMed ID: 10988039
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of moclobemide with selective serotonin reuptake inhibitors (SSRIs) on sexual function in depressed adults. The Australian and German Study Groups.
    Philipp M; Tiller JW; Baier D; Kohnen R
    Eur Neuropsychopharmacol; 2000 Sep; 10(5):305-14. PubMed ID: 10974600
    [TBL] [Abstract][Full Text] [Related]  

  • 50. WITHDRAWN: Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depression.
    Geddes JR; Freemantle N; Mason J; Eccles MP; Boynton J
    Cochrane Database Syst Rev; 2007 Jul; 2006(3):CD001851. PubMed ID: 17636689
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Are SSRIs true antidepressant drugs? A plea for the re-evaluation of their therapeutic potential and safety.
    Loonen AJ
    Pharm World Sci; 1997 Apr; 19(2):70-2. PubMed ID: 9151344
    [No Abstract]   [Full Text] [Related]  

  • 52. Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders.
    Marek GJ; Carpenter LL; McDougle CJ; Price LH
    Neuropsychopharmacology; 2003 Feb; 28(2):402-12. PubMed ID: 12589395
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of synaptic serotonin level on [18F]altanserin binding to 5HT2 receptors in man.
    Larisch R; Klimke A; Hamacher K; Henning U; Estalji S; Hohlfeld T; Vosberg H; Tosch M; Gaebel W; Coenen HH; Müller-Gärtner HW
    Behav Brain Res; 2003 Feb; 139(1-2):21-9. PubMed ID: 12642173
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The impact of antidepressants on seizure frequency and depressive and anxiety disorders of patients with epilepsy: Is it worth investigating?
    Ribot R; Ouyang B; Kanner AM
    Epilepsy Behav; 2017 May; 70(Pt A):5-9. PubMed ID: 28407526
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response.
    Blier P; Bergeron R; de Montigny C
    Neuropsychopharmacology; 1997 May; 16(5):333-8. PubMed ID: 9109104
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fluorine magnetic resonance spectroscopy measurement of brain fluvoxamine and fluoxetine in pediatric patients treated for pervasive developmental disorders.
    Strauss WL; Unis AS; Cowan C; Dawson G; Dager SR
    Am J Psychiatry; 2002 May; 159(5):755-60. PubMed ID: 11986128
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Agonist induced-phosphorylation of Galpha11 protein reduces coupling to 5-HT2A receptors.
    Shi J; Damjanoska KJ; Singh RK; Carrasco GA; Garcia F; Grippo AJ; Landry M; Sullivan NR; Battaglia G; Muma NA
    J Pharmacol Exp Ther; 2007 Oct; 323(1):248-56. PubMed ID: 17646429
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dysthymia and serotonin.
    Lapierre YD; Ravindran A; Bakish D
    Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():87-90. PubMed ID: 8201250
    [No Abstract]   [Full Text] [Related]  

  • 59. Chronic fluoxetine differentially affects 5-hydroxytryptamine (2A) receptor signaling in frontal cortex, oxytocin- and corticotropin-releasing factor-containing neurons in rat paraventricular nucleus.
    Damjanoska KJ; Van de Kar LD; Kindel GH; Zhang Y; D'Souza DN; Garcia F; Battaglia G; Muma NA
    J Pharmacol Exp Ther; 2003 Aug; 306(2):563-71. PubMed ID: 12721328
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic predictors of response to antidepressants in the GENDEP project.
    Uher R; Huezo-Diaz P; Perroud N; Smith R; Rietschel M; Mors O; Hauser J; Maier W; Kozel D; Henigsberg N; Barreto M; Placentino A; Dernovsek MZ; Schulze TG; Kalember P; Zobel A; Czerski PM; Larsen ER; Souery D; Giovannini C; Gray JM; Lewis CM; Farmer A; Aitchison KJ; McGuffin P; Craig I
    Pharmacogenomics J; 2009 Aug; 9(4):225-33. PubMed ID: 19365399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.